Weight loss jabs could leave users 'worse off than before' if they pile fat back on when they stop taking them, researchers warn. People taking the likes of Mounjaro or Wegovy will regain almost two ... MarketWatch: FDA approves Novo Nordisk's Wegovy(R) pill, the first and only oral GLP-1 for weight loss in adults The MarketWatch News Department was not involved in the creation of this content.

Understanding the Context

-- Average weight loss of 17% if all patients stayed on treatment* with Wegovy(R) (semaglutide) tablets 25 mg (14% ... FDA approves Novo Nordisk's Wegovy(R) pill, the first and only oral GLP-1 for weight loss in adults MSN: Why weight loss jabs can leave you worse off than before after stopping them Why weight loss jabs can leave you worse off than before after stopping them Healthline: Can You Maintain Weight Loss With Fewer Injections of Ozempic, Wegovy? Seeking Alpha: FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile